Image assisted laser therapies for oncology
Professor Vanderlei Salvador Bagnato has a PhD from MIT (1987). He graduated with Honors, at the same time, in Materials Engineering (Federal University of São Carlos - Brazil - 1981) and in [...]
Visit of Prof. Bréchet to northern france branch of the CEA to discuss relationships with local actors in research and innovation
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.
Save the date: Update PDT-PDD 2020 will be held in Nancy, France!
OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
The INDYGO clinical trial presented during the annual EANS meeting
On November 8th and 9th, 2018, the Cancéropole Nord-Ouest organized the second edition of the "Translationnelles" days: "Ovarian cancer - from biology to clinic" in Caen, France.
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Third place for OncoThAI